Molecular characteristics of mantle cell lymphoma presenting with clonal plasma cell component

American Journal of Surgical Pathology

Volumn 35, Issue 2, 2011, Pages 177-189

  Visco, Carlo ^a,b,c   Hoeller, Sylvia ^d   Malik, Jeffrey T ^a   Xu Monette, Zijun Y ^a   Wiggins, Michele L ^e   Liu, Jessica ^e   Sanger, Warren G ^e   Liu, Zhongfeng ^e   Chang, Julie ^a   Ranheim, Erik A ^a   Gradowski, Joel F ^f   Serrano, Sergio ^g   Wang, Huan You ^h   Liu, Qingquan ⁱ   Dave, Sandeep ⁱ   Olsen, Brian ^j   Gascoyne, Randy D ^k   Campo, Elias ^l   Swerdlow, Steven H ^f   Chan, Wing C ^e   Tzankov, Alexander ^d   Young, Ken H ^m   more..

^a Laboratory Medicine   (United States)

^b UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^c SAN BORTOLO HOSPITAL   (Italy)

^d UNIVERSITY HOSPITAL BASEL   (Switzerland)

^e UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^f UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^g UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^h UNIVERSITY OF CALIFORNIA   (United States)

ⁱ DUKE UNIVERSITY   (United States)

^j Ingham Regional Medical Center   (United States)

^k BRITISH COLUMBIA CANCER AGENCY   (Canada)

^l UNIVERSITY OF BARCELONA   (Spain)

^m UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

more..

Author keywords

cyclin D1; mantle cell lymphoma; monotypic plasma cells; plasma cells; plasmacytic differentiation

Indexed keywords

DNA; IMMUNOGLOBULIN HEAVY CHAIN; TUMOR MARKER;

AGED; ARTICLE; CELL CLONE; CHROMOSOME 11; CHROMOSOME 14; CLINICAL TRIAL; ENZYME IMMUNOASSAY; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE TRANSLOCATION; GENETICS; HUMAN; IMMUNOPHENOTYPING; LYMPHOID TISSUE; MALE; MANTLE CELL LYMPHOMA; METABOLISM; MICRODISSECTION; MIDDLE AGED; MULTICENTER STUDY; PATHOLOGY; PLASMA CELL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

AGED; AGED, 80 AND OVER; CHROMOSOMES, HUMAN, PAIR 11; CHROMOSOMES, HUMAN, PAIR 14; CLONE CELLS; DNA, NEOPLASM; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; IMMUNOGLOBULIN HEAVY CHAINS; IMMUNOPHENOTYPING; IN SITU HYBRIDIZATION, FLUORESCENCE; LYMPHOID TISSUE; LYMPHOMA, MANTLE-CELL; MALE; MICRODISSECTION; MIDDLE AGED; PLASMA CELLS; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; TRANSLOCATION, GENETIC; TUMOR MARKERS, BIOLOGICAL;

EID: 79251538108     PISSN: 01475185     EISSN: 15320979     Source Type: Journal    
DOI: 10.1097/PAS.0b013e3182049a9c     Document Type: Article

References (47)

1. Anderson JR, Armitage JO, Weisenburger DD. Epidemiology of the non-Hodgkin's lymphomas: distributions of the major subtypes differ by geographic locations. Non-Hodgkin's Lymphoma Classification Project. Ann Oncol. 1998;9:717-720.
2. Cachia AR, Diss TC, Isaacson PG. Composite mantle-cell lymphoma and plasmacytoma. Hum Pathol. 1997;28:1291-1295.
3. Calame KL, Lin KI, Tunyaplin C. Regulatory mechanisms that determine the development and function of plasma cells. Annu Rev Immunol. 2003;21:205-230.
4. Camacho FI, Algara P, Rodrguez A, et al. Molecular heterogeneity in MCL defined by the use of specific VH genes and the frequency of somatic mutations. Blood. 2003;101:4042-4046.
5. Campo E, Raffeld M, Jaffe ES. Mantle-cell lymphoma. Semin Hematol. 1999;36:115-127.
6. Chiorazzi N, Rai KR, Ferrarini M. Chronic lymphocytic leukemia. N Engl J Med. 2005;352:804-815.
7. Cogliatti SB, Lennert K, Hansmann ML, et al. Monocytoid B cell lymphoma: clinical and prognostic features of 21 patients. J Clin Pathol. 1990;43:619-625.
8. Coupland SE, Hellmich M, Auw-Haedrich C, et al. Plasmacellular differentiation in extranodal marginal zone B cell lymphomas of the ocular adnexa: an analysis of the neoplastic plasma cell phenotype and its prognostic significance in 136 cases. Br J Ophthalmol. 2005;89:352-359.
9. Evans HL, Polski JM, Deshpande V, et al. CD5+ true SLL/CLL with plasmacytic differentiation and an unusual 1p36 translocation: case report and review of the literature. Leuk Lymphoma. 2000; 39:625-632.
10. Fong D, Kaiser A, Spizzo G, et al. Hodgkin's disease variant of Richter's syndrome in chronic lymphocytic leukemia patients previously treated with fludarabine. Br J Haematol. 2005;129:199-205.
11. Fonseca R, Bergsagel PL, Drach J, et al. International Myeloma Working Group. International Myeloma Working Group molecular classification of multiple myeloma: spotlight review. Leukemia. 2009;23:2210-2221.
12. Foy TM, Aruffo A, Bajorath J, et al. Immune regulation by CD40 and its ligand GP39. Annu Rev Immunol. 1996;14:591-617.
13. Fu K, Weisenburger DD, Greiner TC, et al. Cyclin D1-negative mantle cell lymphoma: a clinicopathologic study based on gene expression profiling. Blood. 2005;106:4315-4321.
14. George TI, Wrede JE, Bangs CD, et al. Low-grade B-Cell lymphomas with plasmacytic differentiation lack PAX5 gene rearrangements. J Mol Diagn. 2005;7:346-351.
15. Ghielmini M, Zucca E. How I treat mantle cell lymphoma. Blood. 2009;114:1469-1476.
16. Gradowski JF, Jaffe ES, Warnke RA, et al. Follicular lymphomas with plasmacytic differentiation include two subtypes. Mod Pathol. 2010;23:71-79.
17. Gutierrez NC, Ocio EM, de Las Rivas J, et al. Gene expression profiling of B lymphocytes and plasma cells from Waldenstrom's macroglobulinemia: comparison with expression patterns of the same cell counterparts from chronic lymphocytic leukemia, multiple myeloma and normal individuals. Leukemia. 2007;21:541-549.
18. Hummel M, Tamaru J, Kalvelage B, et al. Mantle cell (previously centrocytic) lymphomas express VH genes with no or very little somatic mutations like the physiologic cells of the follicle mantle. Blood. 1994;84:403-407.
19. Kawano MM, Mihara K, Huang N, et al. Differentiation of early plasma cells on bone marrow stromal cells requires interleukin-6 for escaping from apoptosis. Blood. 1995;85:487-494.
20. Keith TA, Cousar JB, Glick AD, et al. Plasmacytic differentiation in follicular center cell (FCC) lymphomas. Am J Clin Pathol. 1985;84: 283-290.
21. Kojima M, Nakamura S, Motoori T, et al. Primary marginal zone B-cell lymphoma of the lymph node resembling plasmacytoma arising from a plasma cell variant of Castleman's disease: a clinicopathological and immunohistochemical study of seven patients. APMIS. 2002;110:875-880.
22. Kolar GR, Mehta D, Pelayo R, et al. A novel human B cell subpopulation representing the initial germinal center population to express AID. Blood. 2007;109:2545-2552.
23. Lenz G, Staudt LM. Aggressive lymphomas. N Engl J Med. 2010; 362:1417-1429.
24. Lin P, Hao S, Handy BC, et al. Lymphoid neoplasms associated with IgM paraprotein: a study of 382 patients. Am J Clin Pathol. 2005;123:200-205.
25. Martn-Subero JI, Chudoba I, Harder L, et al. Multicolor-FICTION: expanding the possibilities of combined morphologic, immunophenotypic, and genetic single cell analyses. Am J Pathol. 2002;161:413-420.
26. Meier VS, Rufle A, Gudat F. Simultaneous evaluation of T- and B-cell clonality, t(11;14) and t(14;18), in a single reaction by a four-color multiplex polymerase chain reaction assay and automated high-resolution fragment analysis: a method for the rapid molecular diagnosis of lymphoproliferative disorders applicable to fresh frozen and formalin-fixed, paraffin-embedded tissues, blood, and bone marrow aspirates. Am J Pathol. 2001;159:2031-2043.
27. Montes-Moreno S, Gonzalez-Medina AR, Rodriguez Pinilla SM, et al. Aggressive large B cell lymphoma with plasma cell differentiation: immunohistochemical characterization of plasmablastic lympho-ma and diffuse large B cell lymphoma with partial plasmablastic phenotype. Haematologica. 2010;95:1342-1349.
28. Mozos A, Royo C, Hartmann E, et al. SOX11 expression is highly specific for mantle cell lymphoma and identifies the cyclin D1-negative subtype. Haematologica. 2009;94:1555-1562.
29. Naushad H, Choi WW, Page CJ, et al. Mantle cell lymphoma with flow cytometric evidence of clonal plasmacytic differentiation: a case report. Cytometry B Clin Cytom. 2009;76:218-224.
30. O'Connor BP, Gleeson MW, Noelle RJ, et al. The rise and fall of long-lived humoral immunity: terminal differentiation of plasma cells in health and disease. Immunol Rev. 2003;194:61-76.
31. Pileri SA, Falini B. Mantle cell lymphoma. Haematologica. 2009;94: 1488-1492.
32. Preud'homme JL, Gombert J, Brizard A, et al. Serum Ig abnormalities in mantle cell lymphoma. Blood. 1997;90:894-895.
33. Shaffer AL, Lin KI, Kuo TC, et al. Blimp-1 orchestrates plasma cell differentiation by extinguishing the mature B cell gene expression program. Immunity. 2002;17:51-62.
34. Swerdlow SH, Zukerberg LR, Yang WI, et al. The morphologic spectrum of non-Hodgkin's lymphomas with BCL1/cyclin D1 gene rearrangements. Am J Surg Pathol. 1996;20:627-640.
35. Taddesse-Heath L, Meloni-Ehrig A, Scheerle J, et al. Plasmablastic lymphoma with MYC translocation: evidence for a common pathway in the generation of plasmablastic features. Mod Pathol. 2010;23:991-999.
36. Thieblemont C, Nasser V, Felman P, et al. Small lymphocytic lymphoma, marginal zone B-cell lymphoma, and mantle cell lymphoma exhibit distinct gene-expression profiles allowing molecular diagnosis. Blood. 2005;106:4315-4321.
37. Toellner KM, Jenkinson WE, Taylor DR, et al. Low-level hypermutation in T cell independent germinal centers compared with high mutation rates associated with T cell-dependent germinal centers. J Exp Med. 2002;195:383-389.
38. Tunyaplin C, Shaffer AL, Angelin-Duclos CD, et al. Direct repression of prdm1 by Bcl-6 inhibits plasmacytic differentiation. J Immunol. 2004;173:1158-1165.
39. Wan JH, Trainor KJ, Brisco MJ, et al. Monoclonality in B cell lymphoma detected in paraffin wax embedded sections using the polymerase chain reaction. J Clin Pathol. 1990;43:888-890.
40. Wang HY, Karandikar N, Payne D, et al. A 3-way collision tumor of the upper respiratory tract: a composite of 2 immunophenoty-pically distinct mantle cell lymphomas and a plasmacytoma. Hum Pathol. 2008;39:781-787.
41. Weber-Matthiesen K, Winkemann M, Muller-Hermelink A, et al. Simultaneous fluorescence immunophenotyping and interphase cytogenetics: a contribution to the characterization of tumor cells. J Histochem Cytochem. 1992;40:171-175.
42. Weisenburger DD, Armitage JO. Mantle cell lymphoma-an entity comes of age. Blood. 1996;87:4483-4494.
43. Weisenburger DD, Kim H, Rappaport H. Mantle-zone lymphoma: a follicular variant of intermediate lymphocytic lymphoma. Cancer. 1982;49:1429-1438.
44. William J, Euler C, Christensen S, et al. Evolution of autoantibody responses via somatic hypermutation outside of germinal centers. Science. 2002;297:2066-2070.
45. Yamaguchi M, Ohno T, Miyata E, et al. Analysis of clonal relationship using single-cell polymerase chain reaction in a patient with concomitant mantle cell lymphoma and multiple myeloma. Int J Hematol. 2001;73:383-385.
46. Young KH, Chan WC, Fu K, et al. Mantle cell lymphoma with plasma cell differentiation. Am J Surg Pathol. 2006;30:q954-961.
47. Zupo S, Massara R, Dono M, et al. Apoptosis or plasma cell differentiation of CD38-positive B-chronic lymphocytic leukemia cells induced by cross-linking of surface IgM or IgD. Blood. 2000; 95:1199-1206.